Time-restricted feeding for immune health in people with severe obesity
Official title: Exploring the Effects of Time-Restricted Feeding on the Immune Function of Obese Individuals: A Multi-Omic Approach
Run by Hospital Universitari Vall d'Hebron Research Institute · NCT06858683 · Data updated 2026-11-12
This trial will test whether eating only during an 8-hour window improves immune function in adults with severe obesity who are preparing for bariatric surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 64 Years |
| Sex | Women only |
| Enrollment | 45 (estimated) |
| Sponsor | Hospital Universitari Vall d'Hebron Research Institute Academic / other |
| Locations | 1 site (Barcelona) |
| Status | Recruiting |
| Started | March 21, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | June 8, 2025 |
| Trial ID | NCT06858683 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18–64 with BMI 40–50 kg/m² who are scheduled for bariatric surgery in about 10–12 weeks, have had stable weight and a three-meal pattern, and can speak Catalan or Spanish and attend Vall d'Hebron in Barcelona.
✕Probably not a fit
People with type 1 or type 2 diabetes, major cardiovascular disease, current pregnancy, recent cancer, use of immunosuppressive or interfering medications, night-shift workers, or those who cannot follow the language or location requirements are unlikely to benefit or are ineligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with obesity (BMI 40–50 kg/m²) scheduled for bariatric surgery will be randomized to follow time-restricted feeding (8-hour eating window) or a standard longer eating window for about 10–12 weeks before surgery. Researchers will collect blood and tissue samples and use multi-omics techniques to profile immune cells and how white fat cells respond to the diet change. The trial compares immune function and molecular signatures between the two groups to identify mechanisms linking feeding time to immune competence. Outcomes aim to define whether TRF can restore immune responses impaired in severe obesity and how adipocytes contribute to those changes.
Why it matters
Potential benefit: If successful, the intervention could improve immune function and reduce immune-related complications around bariatric surgery for people with severe obesity.
How similar studies have gone: Previous time-restricted feeding studies have shown metabolic benefits, but using TRF specifically to modify immune function and adipocyte immunomodulation is relatively novel and less well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients with obesity * Women * Age 18-64 years * Body mass Index between 40-50 kg/m² * Scheduled bariatric surgery 10-12 weeks after the nutritional intervention * Self-reported eating pattern window of more than 14h * Three meal eating pattern * Stable body weight (less than 10% of current body weight during the last 3 months) * Patients who have a favorable decision from the multidisciplinary team meetings after multidisciplinary nutritional follow-up of at least 6 months and history of failure with non-surgical weight loss methods * Social security affiliation * Written consent * Good understanding of the Catalan or Spanish languages Exclusion Criteria: * Diabetes type I or II * Major cardiovascular disease * Pregnancy * Medication that could affect the study outcomes (i.e. anti-inflammatory drugs, antibiotics, immunosuppressors) * Use products intended for weight loss * Night work shift * Past record of malignant tumors * Serious liver dysfunction or chronic kidney disease * Eating disorders * Chronic viral disease (Hepatitis B or C, HIV) or inflammatory systemic diseases (i.e. Crohn's disease, rheumatoid arthritis) * Serious cardiovascular or cerebrovascular disease within 6 months before randomization * Severe gastrointestinal diseases or gastrointestinal surgery in the 12 months before randomization * Under guardianship, curatorship, deprived of liberty * Unable or unwilling to sign the informed consent form.
Where it's running
-
Vall Hebron Barcelona Hospital Campus
Barcelona, Spain Recruiting
Study contacts
- Study coordinator: Josep A. Villena Delgado
- Email: josep.villena@vhir.org
- Phone: + 34 937372429
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive changes after bariatric surgery using VR Neurotracker and Neuropsi testing
This study will test whether bariatric surgery combined with virtual‑reality Neurotracker sessions improves thinking and memory in adults with morbid obesity scheduled for surgery.
-
Short-term effects of ultra-processed foods on metabolism
This project will test whether a short-term diet high in ultra-processed foods versus a nutrient- and energy-matched low-UPF diet changes appetite and how much adults with BMI 18.5–30 eat.
-
Validating lab assays, IV catheter techniques, and devices for endocrine, cardiometabolic, and musculoskeletal conditions
This project will test whether laboratory assays, IV catheter methods, and equipment give consistent, reliable results in adults with or without obesity-related, metabolic, or musculoskeletal conditions.
-
Improving team-based biopsychosocial training so clinics can deliver recommended obesity care
This project will test two training methods to help clinic teams (primary care clinicians, behavioral health staff, dietitians, and community health workers) deliver USPSTF-recommended obesity care to patients at Federally Qualified Health Centers.
-
See if same day discharge after bariatric surgery is safe for select patients
This trial tests whether people having sleeve gastrectomy or gastric bypass can go home the same day or should stay at least one night, to see if ER visits within a week differ.
-
Evaluating smoking cessation using e-cigarettes and nicotine therapy
This study is testing whether using e-cigarettes or nicotine replacement therapy can help people with obesity who smoke quit smoking and manage their weight better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.